Jane Huang - Nov 30, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Nov 30, 2021
Transactions value $
-$377,493
Form type
4
Date filed
12/2/2021, 05:21 PM
Previous filing
Nov 19, 2021
Next filing
Dec 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Award $0 +14.8K +10.2% $0.00 160K Nov 30, 2021 Direct F1
transaction BGNE American Depositary Shares Award $0 +1.05K $0.00 1.05K Nov 30, 2021 Direct F1, F2
transaction BGNE American Depositary Shares Sale -$189K -530 -50.52% $357.32 519 Dec 1, 2021 Direct F2, F3, F4
transaction BGNE American Depositary Shares Sale -$188K -519 -100% $362.45 0 Dec 1, 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions.
F2 Each American Depositary Share represents 13 Ordinary Shares.
F3 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a performance-based restricted share unit award previously granted to the Reporting Person.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.158 to $357.595, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.